Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloproliferative Neoplasms (MPNs)”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04763928
What this trial is testing

Trial in AML Secondary to MPNs Patients, Unfit for Intensive Chemotherapy, Investigating a Treatment Combination Including Decitabine and Venetoclax

Who this might be right for
Acute Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 101
Not applicableNot Yet RecruitingNCT07349134
What this trial is testing

WELL-MPN: A Digital Lifestyle App for Patients With MPNs

Who this might be right for
Myeloproliferative Neoplasms (MPNs)
Brigham and Women's Hospital 75
Not applicableStudy completedNCT04153305
What this trial is testing

European Registry for Myeloproliferative Neoplasms (MPNs) - Update of ERNEST Study

Who this might be right for
Myelofibrosis
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS 1,010
Early research (Phase 1)Looking for participantsNCT03326310
What this trial is testing

Selumetinib and Azacitidine in High Risk Chronic Blood Cancers

Who this might be right for
Chronic Myeloid LeukemiaMyelofibroses
University of Chicago 18
Not applicableLooking for participantsNCT02760238
What this trial is testing

Myeloproliferative Neoplasms (MPNs) Patient Registry

Who this might be right for
Primary MyelofibrosisPolycythemia VeraEssential Thrombocythemia+7 more
University Health Network, Toronto 5,000
Testing effectiveness (Phase 2)Ended earlyNCT02718300
What this trial is testing

INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis

Who this might be right for
MPN (Myeloproliferative Neoplasms)
Incyte Corporation 74
Testing effectiveness (Phase 2)Looking for participantsNCT06063486
What this trial is testing

Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms

Who this might be right for
Clonal Cytopenia of Undetermined SignificanceEssential ThrombocythemiaMyelodysplastic Syndrome+2 more
University of Southern California 30
Not applicableNot Yet RecruitingNCT06647706
What this trial is testing

Prevalence and Risk Factors of Pulmonary Hypertension in Patients with Myeloproliferative Neoplasms in Assiut University Hospital.

Who this might be right for
Myeloproliferative Neoplasm
Assiut University 100
Not applicableStudy completedNCT01878916
What this trial is testing

Plasma Vitamin and Homocysteine Levels and Thrombosis in Patients With Ph-negative MPNs

Who this might be right for
Thrombosis
Istanbul University
Early research (Phase 1)Looking for participantsNCT05423691
What this trial is testing

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

Who this might be right for
Myelofibrosis
Cellenkos, Inc. 24
Not applicableNot Yet RecruitingNCT06753279
What this trial is testing

Clinical Significance of Leukocyte Cell Population Data in Patients With Myeloproliferative Neoplasms (MPNs)

Who this might be right for
Myeloproliferative Neoplasms (MPNs)
Assiut University 80
Testing effectiveness (Phase 2)Study completedNCT05223920
What this trial is testing

An Extension Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Myeloproliferative Neoplasms (IMG-7289-CTP-202/MK-3543-005)

Who this might be right for
Thrombocythemia, EssentialPrimary Myelofibrosis
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) 81
Not applicableUnknownNCT05782985
What this trial is testing

Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs

Who this might be right for
Myeloproliferative Neoplasms (MPNs)
Assiut University 52
Early research (Phase 1)Looking for participantsNCT06291987
What this trial is testing

Ivosidenib and Ruxolitinib in Patients With Advanced Myeloproliferative Neoplasms (MPNs) That Have an IDH1 Gene Mutation

Who this might be right for
Myeloproliferative Neoplasms
University of Chicago 18
Not applicableStudy completedNCT04605211
What this trial is testing

A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors

Who this might be right for
Myeloproliferative NeoplasmChronic Phase Chronic Myelogenous LeukemiaChronic Myeloid Leukemia
University of California, San Francisco 47
Not applicableActive Not RecruitingNCT03618485
What this trial is testing

Registry of Patients With MPNs in Taiwan

Who this might be right for
Myeloproliferative Neoplasms
Chang Gung Memorial Hospital 500
Not applicableLooking for participantsNCT07362225
What this trial is testing

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

Who this might be right for
Polycythemia VeraET (Essential Thrombocythemia)Polycythemia Vera (PV)+52 more
MPN Research Foundation 5,000
Early research (Phase 1)Looking for participantsNCT07469891
What this trial is testing

PRT12396 in Participants With Select Myeloproliferative Neoplasms

Who this might be right for
Polycythemia Vera (PV)Myelofibrosis (MF)Myeloproliferative Neoplasms (MPNs)+3 more
Prelude Therapeutics Incorporated 100
Testing effectiveness (Phase 2)Looking for participantsNCT06661915
What this trial is testing

Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

Who this might be right for
Accelerated Phase Myeloproliferative NeoplasmBlast Phase Myeloproliferative NeoplasmEssential Thrombocythemia+5 more
National Cancer Institute (NCI) 78
Testing effectiveness (Phase 2)Ended earlyNCT04103645
What this trial is testing

Intra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib in Treating Anemic MPN Patients

Who this might be right for
Myeloproliferative Neoplasm
Weill Medical College of Cornell University 2
Next Page